Text Size

Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

This study is not yet open for participant recruitment.
Verified August 2012 by University of Cologne
Sponsor:
Information provided by (Responsible Party):
Helmar Lehmann, University of Cologne
ClinicalTrials.gov Identifier:
NCT01655394
First received: July 30, 2012
Last updated: August 6, 2012
Last verified: August 2012
History of Changes
  Purpose

IVIg exert a variety of different immunomodulatory effects and several mechanism of action have been proposed for IVIg. In this study the role of IVIg on short term nerve conduction and IgG dimer complexes in patients with immune-mediated neuropathies will be explored.


Condition
Guillain-Barre Syndrome
CIDP
Multifocal Motor Neuropathy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Change of Nerve Conduction Properties in IVIg Dependent Neuropathies

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Cologne:

Estimated Enrollment: 50
Study Start Date: October 2012
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

patients with immune neuropathies

Criteria

Inclusion Criteria:

  • immune neuropathy
  • age above 18 y
  • IVIg treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01655394

Contacts
Contact: Helmar C. Lehmann, PD Dr. med. helmar.lehmann@uk-koeln.de

Sponsors and Collaborators
University of Cologne
Investigators
Principal Investigator: Helmar C. Lehmann, PD Dr. med. PI
  More Information

No publications provided

Responsible Party: Helmar Lehmann, PD Dr. med. H. Lehmann, University of Cologne
ClinicalTrials.gov Identifier: NCT01655394     History of Changes
Other Study ID Numbers: 01607831337
Study First Received: July 30, 2012
Last Updated: August 6, 2012
Health Authority: Germany: University of Cologne

Additional relevant MeSH terms:
Guillain-Barre Syndrome
Neuritis
Demyelinating Diseases
Polyneuropathies
Nerve Compression Syndromes
Neurologic Manifestations
Neurotoxicity Syndromes
Polyradiculoneuropathy
Autoimmune Diseases of the Nervous System
 Nervous System Diseases
Peripheral Nervous System Diseases
Neuromuscular Diseases
Autoimmune Diseases
Immune System Diseases
Signs and Symptoms
Poisoning
Substance-Related Disorders

ClinicalTrials.gov processed this record on May 19, 2013